BOLT SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action
NEWTOWN, Pa., July 12, 2024 /PRNewswire/ -- Edelson Lechtzin LLP, a leading class action law firm, reminds investors about the…
